CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 43 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -99.9% | 1,750 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,750 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 1,750 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 1,750 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -50.0% | 1,750 | 0.0% | 0.00% | – |
| Q3 2021 | $8,000 | +33.3% | 1,750 | -30.0% | 0.00% | – |
| Q2 2021 | $6,000 | -14.3% | 2,500 | 0.0% | 0.00% | – |
| Q1 2021 | $7,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,501,161 | 1.96% |
| TOWERVIEW LLC | 205,000 | $469,450 | 0.31% |
| Orbimed Advisors | 6,943,654 | $15,900,968 | 0.29% |
| CHI Advisors LLC | 200,000 | $458,000 | 0.14% |
| BVF INC/IL | 1,370,947 | $3,139,469 | 0.09% |
| SAMLYN CAPITAL, LLC | 2,105,930 | $4,822,580 | 0.08% |
| MYDA Advisors LLC | 100,000 | $229,000 | 0.07% |
| DIFESA CAPITAL MANAGEMENT, LP | 10,000 | $22,900 | 0.06% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $146,040 | 0.06% |
| CORNERCAP INVESTMENT COUNSEL INC | 97,248 | $222,698 | 0.04% |